Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

NCT02538432 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI No Longer at University of Maryland. Now at Fox Chase

Conditions

Prostate Cancer
Non-Small Cell Lung Cancer
Breast Cancer

Interventions

DRUG: RQ-00000007
DRUG: Gemcitabine

Sponsor

University of Maryland, Baltimore